Clinical characteristics and hospital charges among Thai children hospitalized with influenza

Insights

Severe influenza in Thai children is common, especially in those under five. While most recover, young children and those with comorbidities face longer hospital stays and higher costs.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Virology
  • Health Economics

Background:

  • Infants and young children face significant risks from influenza, including severe illness, death, and hospitalization.
  • Data on clinical characteristics, outcomes, and economic impact of severe influenza in hospitalized Thai children are limited.

Purpose of the Study:

  • To investigate the clinical findings, outcomes, and financial burden associated with severe influenza in hospitalized children in Thailand.

Main Methods:

  • Retrospective review of 289 hospitalized influenza cases at Queen Sirikit National Institute of Child Health, Bangkok.
  • Influenza diagnosis confirmed by real-time reverse transcriptase-polymerase chain reaction or rapid testing.
  • Analysis of patient demographics, symptoms, comorbidities, treatment, and hospital charges.

Main Results:

  • Influenza A was the predominant type (70.6%). Children under 5 years accounted for 60.9% of cases.
  • Fever (100%), cough (90.3%), and rhinorrhea (70.6%) were most common. Diarrhea and thrombocytopenia occurred in 22% and 10.4%, respectively.
  • The fatality rate was 0.7%. Median hospitalization was 3 days, with a median charge of USD 169.4. Younger age (<2 years), comorbidities, and oseltamivir treatment correlated with longer stays and higher costs.

Conclusions:

  • Most children hospitalized with influenza experience an uncomplicated course.
  • Younger children (<2 years) are an independent risk factor for severe disease.
  • Predisposing comorbidities and oseltamivir treatment increase hospitalization duration and costs, highlighting the need for targeted prevention and management strategies in pediatric influenza.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
79
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
6.6K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K